EzySpot

Similar stories

Worldwide Diabetes Reusable Insulin Delivery Pen Market Outlook 2026 34 weeks 5 days ago

“Worldwide Diabetes Reusable Insulin Delivery Pen Market: Demand, Insights, Trends, Analysis, Opportunities, Growth Potential and Forecast to 2026” is based on comprehensive research of the worldwide diabetes reusable insulin delivery pen market. The report offers the most up-to-date industry data on the actual market situation and future outlook for the worldwide diabetes reusable insulin delivery pen market. The report provides historical market data for 2013 – 2019, and forecasts from 2020 until 2026.

Worldwide – Insulin Pump Market & Forecast 3 years 29 weeks ago

For the year 2013 United States is having the highest market share in insulin pump market worldwide. In terms of companies share Medtronic controls a major portion of insulin pump market globally. Insulin pump market is more than 4 Billion for the year 2013. Reimbursement plays an important factor for the growth of insulin pump in any country.

Global Insulin Pump Market is expected to cross US$ 8 Billion by 2024 3 years 14 weeks ago

By the year 2024, global insulin pump market is expected to cross US$ 8 Billion. For decades, a surrogate for incursive insulin needles — tablets or insulin delivered via inhalable pumps is seen as a Holy Grail but scientific attempt has so far achieved inadequate success. Although, there is good news for a lot of diabetes patients by the introduction of “Insulin Pump”.
Renub research predicts that the worldwide insulin pump market has increased with a vital growth rate over the years and is anticipated to rise further during the forecast period (2017-2024). The global insulin pump market growth drivers such as ageing population, rise in diabetic population and evolution of new products. Though, the market faces certain hurdles like a threat from the implantable insulin pump, the high cost of insulin pumps, complicated software used in insulin pumps and invention of artificial pancreas etc.

United States – Insulin Pump Users Market & Forecast 3 years 23 weeks ago

USA insulin pump market is expected to grow more than US$ 5 Billion by the end of year 2022. The convenience of using insulin pump are gaining inclusive acceptance in the market as insulin delivery systems. Now insulin Pump has become famous and a preferred device for Type1 diabetes patients in the United States. Insulin Pump market constitutes comparatively small portion of total Insulin Delivery Systems market.

US Insulin Pump Market & Forecast 3 years 21 weeks ago

US insulin pump market is projected to cross US$ 5 Billion by end of the year 2022. A medical device which is used for the management of insulin in the treatment of diabetes is called “Insulin Pump”. Insulin Pump is a small programme device similar to mobile phone. It is very convenient to use, as this can be easily carried out. The device contains buttons to program insulin and navigates through the menu.

Diabetes Drug Market Future Outlook 2 years 12 weeks ago

Global diabetes drug market is expected US$ 76 Billion by 2024. Renub Research report titled “Diabetes Drug Market, Oral (DPP IV Inhibitor, SGLT-2, Alpha Glucosidase Inhibitor, Biguanide) Injection (Glucagon-like peptide (GLP) 1 agonist, Amylin Receptor Agonist), Insulin (Rapid – Acting Insulin, Long Acting Insulin, Premixed Insulin), Regions (United States, Europe, Japan, China, India, Brazil), Companies (Novo Nordisk, Merck & Co, Eli Lilly, AstraZeneca, Johnson & Johnson, Boehringer Ingelheim)” provides Diabetes Drug Market.

Globally Osteoporosis is expected to be more than US$ 40 Billion market by 2019 3 years 33 weeks ago

Osteoporosis is a silent disease until it is complicated by fractures that occur following minimal trauma or, in some cases, with no trauma. Globally Osteoporosis is expected to be more than US$ 40 Billion market by 2019. China and India together have close to 80% of osteoporosis patients worldwide. Whereas this in case of hip fracture cases both the countries China and India have more than 60% patients. But when we study Osteoporosis in market terms then United States controls the highest market share followed by China and Japan. Amgen and Eli Lilly are two dominant players in Osteoporosis drugs market.
This is the 2nd edition report on Osteoporosis by Renub Research. Report titled “Global Osteoporosis Market, Patients, Companies & Forecast” provides a comprehensive analysis of the current state of this market and likely future evolution over the next 5 years. This 124 page report with 89 Figures and 8 Tables studies the Worldwide Osteoporosis market.